Stockholm Stock Exchange | Mid Cap
Camurus
-10.71%
Latest
-1.31%
3 months
CarnegieDNBNordea MarketsPareto SecuritiesBryan GarnierHandelsbanken Capital MarketsJefferies InternationalJefferiesHandelsbankenDNB Markets

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia